+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

COVID-19 Nasal Swab Test Market, by Product Type, by Diagnostics Type, by Mode, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 168 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5456019
COVID-19 infection is caused by SARS-CoV-2, which is a highly transmissible and life-threatening strain of coronavirus. Nasal swab is a method used for collecting clinical test samples of nasal secretions. Nasal swabs can be used for analysis of number of infectious diseases such as whooping cough, influenza, SARS, COVID-19, and others. Rising burden of COVID-19 cases across the world has created a huge opportunity for growth of COVID-19 nasal swab market. These nasal swabs can be used in laboratories as well as in the comfort of one’s home. The collection procedure must be carried out with extreme precautions as any contamination of the nasal swab may lead to wrong results. The collected nasal secretion sample is placed into a transporting medium that provides a stable environment to the sample. This transporting liquid medium is subjected to further diagnostic tests to detect the presence of SARS-CoV-2 in the nasal specimen.



Market Dynamics


Market players and private healthcare organizations are focused on conducting research activities for developing more efficient nasal swabs for detection of COVID-19 infection, which could contribute to the growth of the COVID-19 nasal swab test market over the forecast period. For instance, in March 2020, PATH, Mayo Clinic and Bill and Melinda Gates Foundation initiated an observational clinical study to compare the efficiency of foam nasal swabs and polyester nasal swabs in diagnosis of COVID-19 infection. This study was completed in October 2020, and it also focused on observing the trajectory of COVID-19 at different stages of infection.

Market players are focused on launch of products, which is expected to strengthen their position in the global COVID-19 nasal swab test market. For instance, in November 2020, Tata Medical and Diagnostics launched its product TataMD CHECK, a nasal swab test that is able to diagnose COVID-19 within 90 minutes.

Market players are involved in expanding their presence globally by entering into partnership with other companies in order to enhance distribution, this is expected to drive the growth of the COVID-19 nasal swab test market. For instance, in January 2021, iMFLUX, Inc., an American molding company entered into a partnership with Rhinostics, Inc., a Harvard University startup, to develop polypropylene COVID-19 nasal swab, which is cost effective and allows easy collection of nasal secretion.

Key features of the study:

  • This report provides an in-depth analysis of global COVID-19 nasal swab test market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global COVID-19 nasal swab test market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc.,Siemens Healthineers AG, QIAGEN N.V., Cepheid, LumiraDx Ltd., Fluidigm Corporation, Quidel Corporation, GenMark Diagnostics, Inc., Sherlock Biosciences, PrivaPath Diagnostics Limited, and OraSure Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global COVID-19 nasal swab test market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the COVID-19 nasal swab test market

Detailed Segmentation:


Global COVID-19 Nasal Swab Test Market, By Product Type:

  • Foam Tipped Swabs
  • Non-Woven
  • Others

Global COVID-19 Nasal Swab Test Market, By Diagnostics Type:

  • Molecular Diagnostics
  • CRISPR & Biosensors
  • Others

Global COVID-19 Nasal Swab Test Market, By Mode:

  • Point-of-Care
  • Non Point-of-Care

Global COVID-19 Nasal Swab Test Market, By End User:

  • Hospital & Clinic
  • Laboratories & Diagnostics Centers
  • Others

Global COVID-19 Nasal Swab Test Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa

By Country/Region:

  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Abbott Laboratories*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Roche Holding AG
  • Becton Dickinson & Company
  • 3M Corporation
  • BioMerieux SA
  • Lucira Health
  • Mesa Biotech, Inc.
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • Cepheid
  • LumiraDx Ltd.
  • Fluidigm Corporation
  • Quidel Corporation
  • GenMark Diagnostics, Inc.
  • Sherlock Biosciences
  • PrivaPath Diagnostics Limited
  • OraSure Technologies, Inc.
Frequently Asked Questions about the COVID-19 Nasal Swab Test Market

What is the estimated value of the COVID-19 Nasal Swab Test Market?

The COVID-19 Nasal Swab Test Market was estimated to be valued at $111.3 Million in 2021.

What is the growth rate of the COVID-19 Nasal Swab Test Market?

The growth rate of the COVID-19 Nasal Swab Test Market is 2.6%, with an estimated value of $133.2 Million by 2028.

What is the forecasted size of the COVID-19 Nasal Swab Test Market?

The COVID-19 Nasal Swab Test Market is estimated to be worth $133.2 Million by 2028.

Who are the key companies in the COVID-19 Nasal Swab Test Market?

Key companies in the COVID-19 Nasal Swab Test Market include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech Inc., Siemens Healthineers AG and Cepheid.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Diagnostics Type
  • Market Snippet, By Mode
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • PEST Analysis
  • Industry Trends
  • Pipeline Analysis
  • Key Highlights
  • Epidemiology
  • Pricing Analysis
  • Reimbursement Scenario
  • Regulatory Scenario
  • Global Supply Chain Analysis

4. COVID - 19 Impact Analysis
  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of COVID-19 Nasal Swab Test
  • Impact of Covid-19 on the COVID-19 Nasal Swab Test Market

5. Global COVID-19 Nasal Swab Test Market, By Product Type, 2017-2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Foam Tipped Swabs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Non-Woven
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global COVID-19 Nasal Swab Test Market, By Diagnostics Type, 2017-2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Molecular Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • CRISPR & Biosensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global COVID-19 Nasal Swab Test Market, By Mode, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Point-of-Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Non Point-of-Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global COVID-19 Nasal Swab Test Market, By End User, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
  • Regional Trends
  • Hospital & Clinic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Laboratories & Diagnostics Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global COVID-19 Nasal Swab Test Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
  • Regional Trends
  • North America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Diagnostics Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Mode, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Landscape
  • Company Profiles
  • Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Roche Holding AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Becton Dickinson & Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • 3M Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • BioMerieux SA
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Lucira Health
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Mesa Biotech, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Siemens Healthineers AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • QIAGEN N.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Cepheid
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • LumiraDx Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Fluidigm Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Quidel Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • GenMark Diagnostics, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Sherlock Biosciences
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • PrivaPath Diagnostics Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • OraSure Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

11. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Roche Holding AG
  • Becton Dickinson & Company
  • 3M Corporation
  • BioMerieux SA
  • Lucira Health
  • Mesa Biotech Inc.
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • Cepheid
  • LumiraDx Ltd.
  • Fluidigm Corporation
  • Quidel Corporation
  • GenMark Diagnostics Inc.
  • Sherlock Biosciences
  • PrivaPath Diagnostics Limited
  • OraSure Technologies Inc.